Literature DB >> 9498451

Capsular transformation of a multidrug-resistant Streptococcus pneumoniae in vivo.

M Nesin1, M Ramirez, A Tomasz.   

Abstract

Several multidrug-resistant (MDR) isolates of Streptococcus pneumoniae recovered from a variety of clinical sources and expressing serotypes 9N, 14, 19F, and 3 could not be distinguished from the capsular type 23 Spanish/USA epidemic clone in antibiotype, pulsed-field gel electrophoretic pattern, and restriction fragment length polymorphism types of their penicillin binding protein genes 1A, 2X, and 2B. When tested in a mouse model of virulence, isolates expressing capsular type 3 were lethal for 100% of infected animals within 2 days after intraperitoneal injection of 10(2) cfu/mouse. In contrast, several capsular type 23F isolates belonging to the MDR Spanish/USA clone and recovered from the same site were not lethal, even when injected at the dose of 10(7) cfu/mouse. These data suggest that the pneumococcal isolates expressing serotypes 9N, 14, 19F, and 3 represent products of in vivo capsular transformation events in which the MDR epidemic capsular type 23F Spanish/USA clone was the recipient.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9498451     DOI: 10.1086/514242

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  49 in total

1.  A high incidence of prophage carriage among natural isolates of Streptococcus pneumoniae.

Authors:  M Ramirez; E Severina; A Tomasz
Journal:  J Bacteriol       Date:  1999-06       Impact factor: 3.490

2.  Comparative genetics of capsular polysaccharide biosynthesis in Streptococcus pneumoniae types belonging to serogroup 19.

Authors:  J K Morona; R Morona; J C Paton
Journal:  J Bacteriol       Date:  1999-09       Impact factor: 3.490

3.  Molecular characterization of Streptococcus pneumoniae type 4, 6B, 8, and 18C capsular polysaccharide gene clusters.

Authors:  S M Jiang; L Wang; P R Reeves
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

4.  Distribution of the mosaic structured murM genes among natural populations of Streptococcus pneumoniae.

Authors:  S R Filipe; E Severina; A Tomasz
Journal:  J Bacteriol       Date:  2000-12       Impact factor: 3.490

5.  Genetic relatedness within serotypes of penicillin-susceptible Streptococcus pneumoniae isolates.

Authors:  K Overweg; D Bogaert; M Sluijter; J Yother; J Dankert; R de Groot; P W Hermans
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

6.  Streptococcus pneumoniae isolates with reduced susceptibility to ciprofloxacin in Spain: clonal diversity and appearance of ciprofloxacin-resistant epidemic clones.

Authors:  L Alou; M Ramirez; C García-Rey; J Prieto; H de Lencastre
Journal:  Antimicrob Agents Chemother       Date:  2001-10       Impact factor: 5.191

7.  Nomenclature of major antimicrobial-resistant clones of Streptococcus pneumoniae defined by the pneumococcal molecular epidemiology network.

Authors:  L McGee; L McDougal; J Zhou; B G Spratt; F C Tenover; R George; R Hakenbeck; W Hryniewicz; J C Lefévre; A Tomasz; K P Klugman
Journal:  J Clin Microbiol       Date:  2001-07       Impact factor: 5.948

Review 8.  Limiting the spread of resistant pneumococci: biological and epidemiologic evidence for the effectiveness of alternative interventions.

Authors:  S J Schrag; B Beall; S F Dowell
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

9.  Contribution of serotype and genetic background to virulence of serotype 3 and serogroup 11 pneumococcal isolates.

Authors:  Lauren J McAllister; Abiodun D Ogunniyi; Uwe H Stroeher; Amanda J Leach; James C Paton
Journal:  Infect Immun       Date:  2011-09-19       Impact factor: 3.441

10.  Serotype 14 variants of the France 9V(-3) clone from Baltimore, Maryland, can be differentiated by the cpsB gene.

Authors:  M Catherine McEllistrem; Anna C Noller; Shyam Visweswaran; Jennifer M Adams; Lee H Harrison
Journal:  J Clin Microbiol       Date:  2004-01       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.